Literature DB >> 8491214

Genotoxicity analysis of N,N-dimethylaniline and N,N-dimethyl-p-toluidine.

M Taningher1, R Pasquini, S Bonatti.   

Abstract

N,N-Dimethylaniline (DMA, CAS No. 121-69-7) and N,N-dimethyl-p-toluidine (DMPT, CAS No. 99-97-8) belong to the N-dialkylaminoaromatics, a chemical class structurally alerting to DNA reactivity. Their applications may be industrial (dye and pesticide intermediates, polymerizing agents) and surgical (polymerization accelerators for the manufacture of bone cements and prosthetic devices), thus implying heterogeneous types of human exposure. Findings of carcinogenicity in rodents and some nonexhaustive genotoxicity data are available for DMA, but to our knowledge no information is available on DMPT concerning either carcinogenicity or any kind of genetic toxicity. To investigate their mechanism of action and mutagenic/carcinogenic potential, DMA and DMPT were analyzed for complementary genotoxicity endpoints, namely, gene mutation in Salmonella (Ames test), structural and numerical chromosome aberrations in hamster V79 cells (micronucleus test, matched with an immunofluorescent staining for kinetochore proteins), and in vivo DNA damage in mouse and rat liver (alkaline DNA elution test). The results essentially indicate that both chemicals are chromosome damaging agents. Indeed, at the maximum nontoxic doses, they proved nonmutagenic in Salmonella (although their toxicity did not allow concentrations > 70 micrograms/plate to be tested) and weakly positive in inducing DNA damage (increases in DNA elution rates at most approximately 2.4 times control value). Conversely, they proved clearly positive in inducing numerical chromosome alterations, with dose-dependent increases up to more than five times the control value for DMPT. At the highest dose tested, both chemicals also showed a significant clastogenic effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491214     DOI: 10.1002/em.2850210406

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  6 in total

1.  Acrylamine-induced autoimmune phenomena.

Authors:  Bruce Rothschild
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

2.  Optimisation of the composition of an acrylic bone cement: application to relative amounts of the initiator and the activator/co-initiator in Surgical Simplex P.

Authors:  S Madigan; M R Towler; G Lewis
Journal:  J Mater Sci Mater Med       Date:  2006-04       Impact factor: 3.896

3.  Influence of two changes in the composition of an acrylic bone cement on its handling, thermal, physical, and mechanical properties.

Authors:  G Lewis; J Xu; S Madigan; M R Towler
Journal:  J Mater Sci Mater Med       Date:  2007-05-05       Impact factor: 4.727

4.  Biological response of new activated acrylic bone cements with antiseptic properties. Histomorphometric analysis.

Authors:  B de la Torre; M Salvado; M A González Corchón; B Vázquez; F Collía; J A De Pedro; J San Román
Journal:  J Mater Sci Mater Med       Date:  2007-01-11       Impact factor: 4.727

5.  ECVAM retrospective validation of in vitro micronucleus test (MNT).

Authors:  Raffaella Corvi; Silvio Albertini; Thomas Hartung; Sebastian Hoffmann; Daniela Maurici; Stefan Pfuhler; Jan van Benthem; Philippe Vanparys
Journal:  Mutagenesis       Date:  2008-03-07       Impact factor: 3.000

6.  The Effect of TBB, as an Initiator, on the Biological Compatibility of PMMA/MMA Bone Cement.

Authors:  Kosuke Hamajima; Ryotaro Ozawa; Juri Saruta; Makiko Saita; Hiroaki Kitajima; Samira Rahim Taleghani; Dan Usami; Donya Goharian; Mitsunori Uno; Ken Miyazawa; Shigemi Goto; Keiichi Tsukinoki; Takahiro Ogawa
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.